1.68
price down icon2.89%   -0.05
after-market Handel nachbörslich: 1.70 0.02 +1.19%
loading

Finanzdaten der In 8 Bio Inc-Aktie (INAB)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
2.73%
0.107
0.11 0.064 0.023 0.06
Operating Expenses
8.11%
5.201
5.66 6.224 7.109 8.689
Benefits Costs and Expenses
8.11%
5.201
5.66 11.78 7.109 8.689
Costs And Expenses
8.11%
5.201
5.66 6.224 7.109 8.689
Operating Income/Loss
8.22%
-5.094
-5.55 -6.16 -7.086 -8.629
Income/Loss From Continuing Operations Before Tax
8.22%
-5.094
-5.55 -11.71 -7.086 -8.629
Income/Loss From Continuing Operations After Tax
8.22%
-5.094
-5.55 -6.16 -7.086 -8.629
Net Income/Loss
8.22%
-5.094
-5.55 -6.16 -7.086 -8.629
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
95.07%
4.1192
83.48 7.8564 47.32 45.13
Diluted Average Shares
95.07%
4.1192
83.48 7.8564 47.32 45.13
Basic Earnings Per Share
1,671%
-1.24
-0.07 -0.04 -0.15 -0.19
Diluted Earnings Per Share
1,671%
-1.24
-0.07 -0.04 -0.15 -0.19
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$38.39
price down icon 1.08%
$95.41
price down icon 0.72%
$31.31
price down icon 3.07%
$94.81
price down icon 1.24%
biotechnology ONC
$319.06
price down icon 0.55%
$197.01
price up icon 0.91%
Kapitalisierung:     |  Volumen (24h):